Valneva Announces New IXIARO Supply Contract with the U.S. Government Worth a Minimum of $32 Million Read more
Jazz Pharmaceuticals Receives European Commission Approval for Enrylaze (a recombinant Erwinia asparaginase or crisantaspase) for the Treatment of Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma Read more
JURA Bio Announces Partnership With Replay Product Company Syena to Advance T Cell Receptor NK Therapies in Cancer Read more
Debiopharm and SunRock Biopharma Partner to Advance Antibody Drug Conjugates for Hard-to-treat Cancers Read more
FDA Accepts for Priority Review Merck’s Supplemental New Drug Application for WELIREG (belzutifan) in Certain Previously Treated Patients With Advanced Renal Cell Carcinoma (RCC) Read more
PeptiDream Announces Collaboration and License Agreement with Genentech for the Discovery and Development of Novel Peptide-Radioisotope Drug Conjugates Read more
BeiGene Strengthens Global Portfolio and Regains Full Rights from Novartis for Anti-PD-1 Antibody TEVIMBRA (tislelizumab) Read more
Otsuka and Astex announce that the European Commission has approved INAQOVI (oral decitabine and cedazuridine) for the treatment of adults with newly diagnosed acute myeloid leukaemia Read more
European Commission Approves Pfizer’s LITFULO for Adolescents and Adults With Severe Alopecia Areata Read more